Evans’ Infections of Humans: Staphylococcal Infections

  • Zeina A. KanafaniEmail author
  • Vance G. FowlerJr

Despite major advances in the medical arena, staphylococci remain important agents of infectious diseases in the human host. Although initially disregarded as contaminants in cultures, coagulase-negative staphylococci have recently gained great clinical significance and are now recognized as potentially virulent pathogens associated with significant morbidity and mortality.(1) The emergence of antibiotic resistance has also brought renewed attention to staphylococci. Methicillin-resistant Staphylococcus aureus (MRSA) is now considered a major public health problem both in the hospital and in community settings.(2–4)


Capsular Polysaccharide Toxic Shock Syndrome Phage Typing Staphylococcal Infection Prosthetic Valve Endocarditis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kloos WE, Bannerman TL. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 1994;7(1):117–40.PubMedGoogle Scholar
  2. 2.
    Calfee DP, Durbin LJ, Germanson TP, Toney DM, Smith EB, Farr BM. Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA. Infect Control Hosp Epidemiol 2003;24(6):422–6.PubMedGoogle Scholar
  3. 3.
    Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 2002;99(11):7687–92.PubMedGoogle Scholar
  4. 4.
    Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279(8):593–8.PubMedGoogle Scholar
  5. 5.
    Ogston A. Report upon micro-organisms in surgical diseases. Br Med J 1881;1:369–75.PubMedGoogle Scholar
  6. 6.
    Rosenbach FJ. Mikro-organismen bei den Wund-Infektions-Krankheiten des Menschen: Wiesbaden: JF Bergmanns Verlag; 1884.Google Scholar
  7. 7.
    Bennett IL, Jr., Beeson PB. Bacteremia: a consideration of some experimental and clinical aspects. Yale J Biol Med 1954;26(4): 241–62.PubMedGoogle Scholar
  8. 8.
    Hart D. Operation room infections. Arch Surg (Chicago) 1937;34:874–96.Google Scholar
  9. 9.
    Fleming A. How I discovered penicillin. J Med (Oporto) 1950;15(380):683.Google Scholar
  10. 10.
    Kenez J. Discovery and Victory of Penicillin. (A. Fleming). Orv Hetil 1965;106:847–50.PubMedGoogle Scholar
  11. 11.
    Lyytikainen O, Ruotsalainen E, Jarvinen A, Valtonen V, Ruutu P. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995–2001. Eur J Clin Microbiol Infect Dis 2005;24(6):399–404.PubMedGoogle Scholar
  12. 12.
    Deryke CA, Lodise TP, Jr., Rybak MJ, McKinnon PS. Epidemiology, treatment, and outcomes of Nosocomial Bacteremic Staphylococcus aureus Pneumonia. Chest 2005;128(3):1414–22.PubMedGoogle Scholar
  13. 13.
    Fidalgo S, Vazquez F, Mendoza MC, Perez F, Mendez FJ. Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features. Rev Infect Dis 1990;12(3):520–8.PubMedGoogle Scholar
  14. 14.
    Osmon S, Ward S, Fraser VJ, Kollef MH. Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest 2004;125(2):607–16.PubMedGoogle Scholar
  15. 15.
    Nahmias AJ, Lepper MH, Hurst V, Mudd S. Epidemiology and treatment of chronic staphylococcal infections in the household. Am J Public Health 1962;52:1828–43.Google Scholar
  16. 16.
    Collignon P, Nimmo GR, Gottlieb T, Gosbell IB. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis 2005;11(4):554–61.PubMedGoogle Scholar
  17. 17.
    Wyllie DH, Peto TE, Crook D. MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997–2003. BMJ 2005;331:992.Google Scholar
  18. 18.
    Hsueh PR, Chen WH, Teng LJ, Luh KT. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents. Int J Antimicrob Agents 2005;26(1):43–9.PubMedGoogle Scholar
  19. 19.
    Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB. Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis 2005;11(6):868–72.Google Scholar
  20. 20.
    Cretnik TZ, Vovko P, Retelj M, et al. Prevalence and nosocomial spread of methicillin-resistant Staphylococcus aureus in a long-term-care facility in Slovenia. Infect Control Hosp Epidemiol 2005;26(2):184–90.PubMedGoogle Scholar
  21. 21.
    Furman CD, Rayner AV, Tobin EP. Pneumonia in older residents of long-term care facilities. Am Fam Physician 2004;70(8):1495–500.PubMedGoogle Scholar
  22. 22.
    Leman R, Alvarado-Ramy F, Pocock S, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus in an American Indian population. Infect Control Hosp Epidemiol 2004;25(2):121–5.PubMedGoogle Scholar
  23. 23.
    Urth T, Juul G, Skov R, Schonheyder HC. Spread of a methicillin-resistant Staphylococcus aureus ST80-IV clone in a Danish community. Infect Control Hosp Epidemiol 2005;26(2):144–9.PubMedGoogle Scholar
  24. 24.
    Mitani N, Koizumi A, Sano R, et al. Molecular typing of Methicillin-Resistant Staphylococcus aureus by PCR-RFLP and its usefulness in an epidemiological study of an outbreak. Jpn J Infect Dis 2005;58(4):250–2.PubMedGoogle Scholar
  25. 25.
    Nagel JG, Sheagren JN, Tuazon CU, Cardella TA. Teichoic acids in pathogenic Staphylococcus aureus. J Clin Microbiol 1977;6(3):233–7.PubMedGoogle Scholar
  26. 26.
    Kleeman KT, Bannerman TL, Kloos WE. Species distribution of coagulase-negative staphylococcal isolates at a community hospital and implications for selection of staphylococcal identification procedures. J Clin Microbiol 1993;31(5):1318–21.PubMedGoogle Scholar
  27. 27.
    Drew WL, Barry AL, O’Toole R, Sherris JC. Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus. Appl Microbiol 1972;24(2):240–7.PubMedGoogle Scholar
  28. 28.
    Barry AL, Badal RE. Reliability of the microdilution technic for detection of methicillin-resistant strains of staphylococcus aureus. Am J Clin Pathol 1977;67(5):489–95.PubMedGoogle Scholar
  29. 29.
    Birnbaum D, Kelly M, Chow AW. Epidemiologic typing systems for coagulase-negative staphylococci. Infect Control Hosp Epidemiol 1991;12(5):319–26.PubMedGoogle Scholar
  30. 30.
    Tveten Y, Kristiansen BE, Ask E, Jenkins A, Hofstad T. DNA fingerprinting of isolates of Staphylococcus aureus from newborns and their contacts. J Clin Microbiol 1991;29(6):1100–5.PubMedGoogle Scholar
  31. 31.
    Ryding U, Espersen F, Soderquist B, Christensson B. Evaluation of seven different enzyme-linked immunosorbent assays for serodiagnosis of Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 2002;42(1):9–15.PubMedGoogle Scholar
  32. 32.
    Wise KA, Tosolini FA. Detection of teichoic acid antibodies in Staphylococcus aureus infections. Pathology 1992;24(2):102–8.PubMedGoogle Scholar
  33. 33.
    Rafiq M, Worthington T, Tebbs SE, et al. Serological detection of Gram-positive bacterial infection around prostheses. J Bone Joint Surg Br 2000;82(8):1156–61.PubMedGoogle Scholar
  34. 34.
    Breckinridge JC, Bergdoll MS. Outbreak of food-borne gastroenteritis due to a coagulase-negative enterotoxin-producing staphylococcus. N Engl J Med 1971;284(10):541–3.PubMedGoogle Scholar
  35. 35.
    Bonventre PF, Weckbach L, Staneck J, Schlievert PM, Thompson M. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect Immun 1983;40(3): 1023–9.PubMedGoogle Scholar
  36. 36.
    Robbins RN, Reiser RF, Hehl GL, Bergdoll MS. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus as determined by tampon disk-membrane-agar method. J Clin Microbiol 1987;25(8):1446–9.PubMedGoogle Scholar
  37. 37.
    Kahler RC, Boyce JM, Bergdoll MS, Lockwood WR, Taylor MR. Toxic shock syndrome associated with TSST-1 producing coagulase-negative staphylococci. Am J Med Sci 1986;292(5):310–2.PubMedGoogle Scholar
  38. 38.
    Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990;248(4956):705–11.PubMedGoogle Scholar
  39. 39.
    Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun 1982;37(1):318–26.PubMedGoogle Scholar
  40. 40.
    Sheth NK, Franson TR, Sohnle PG. Influence of bacterial adherence to intravascular catheters on in-vitro antibiotic susceptibility. Lancet 1985;2(8467):1266–8.PubMedGoogle Scholar
  41. 41.
    Gray ED, Peters G, Verstegen M, Regelmann WE. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1984;1(8373):365–7.PubMedGoogle Scholar
  42. 42.
    Johnson GM, Lee DA, Regelmann WE, Gray ED, Peters G, Quie PG. Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun 1986;54(1):13–20.PubMedGoogle Scholar
  43. 43.
    Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 1982;146(4):479–82.Google Scholar
  44. 44.
    Franson TR, Sheth NK, Menon L, Sohnle PG. Persistent in vitro survival of coagulase-negative staphylococci adherent to intravascular catheters in the absence of conventional nutrients. J Clin Microbiol 1986;24(4):559–61.PubMedGoogle Scholar
  45. 45.
    Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 2005;56(3):455–62.PubMedGoogle Scholar
  46. 46.
    Khoury J, Jones M, Grim A, Dunne WM, Jr., Fraser V. Eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures. Infect Control Hosp Epidemiol 2005;26(7): 616–21.PubMedGoogle Scholar
  47. 47.
    Noskin GA, Rubin RJ, Schentag JJ, et al. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med 2005;165(15):1756–61.PubMedGoogle Scholar
  48. 48.
    Martone WJ, Jarvis WR, Culver DH. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett JV, Brachman PS, eds. Hospital Infections. Boston: Little and Brown; 1992:577–96.Google Scholar
  49. 49.
    Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989. National Nosocomial Infections Surveillance System. Am J Med 1991;91(3B):86S–9S.PubMedGoogle Scholar
  50. 50.
    Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:468–75.Google Scholar
  51. 51.
    Diep BA, Sensabaugh GF, Somboona NS, et al. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 2004;42:2080–4.Google Scholar
  52. 52.
    Purcell K, Fergie JE. Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children. Pediatr Infect Dis J 2002;21(10):988–9.PubMedGoogle Scholar
  53. 53.
    Pan ES, Diep BA, Carleton HA, et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis 2003;37(10):1384–8.PubMedGoogle Scholar
  54. 54.
    Opal SM, Mayer KH, Stenberg MJ, et al. Frequent acquisition of multiple strains of methicillin-resistant Staphylococcus aureus by healthcare workers in an endemic hospital environment. Infect Control Hosp Epidemiol 1990;11(9):479–85.PubMedGoogle Scholar
  55. 55.
    Williams RE. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963;27:56–71.PubMedGoogle Scholar
  56. 56.
    Creech CB, 2nd, Kernodle DS, Alsentzer A, Wilson C, Edwards KM. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 2005;24(7):617–21.PubMedGoogle Scholar
  57. 57.
    Hidron AI, Kourbatova EV, Halvosa JS, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005;41(2): 159–66.PubMedGoogle Scholar
  58. 58.
    Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10(3):505–20.PubMedGoogle Scholar
  59. 59.
    Bibel DJ, Greenberg JH, Cook JL. Staphylococcus aureus and the microbial ecology of atopic dermatitis. Can J Microbiol 1977;23(8):1062–8.PubMedGoogle Scholar
  60. 60.
    Peacock SJ, Justice A, Griffiths D, et al. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol 2003;41(12):5718–25.PubMedGoogle Scholar
  61. 61.
    Benenson S, Zimhony O, Dahan D, et al. Atopic dermatitis–a risk factor for invasive Staphylococcus aureus infections: two cases and review. Am J Med 2005;118(9):1048–51.PubMedGoogle Scholar
  62. 62.
    Luzar MA, Coles GA, Faller B, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990;322(8):505–9.PubMedGoogle Scholar
  63. 63.
    Weinstein HJ. The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. N Engl J Med 1959;260(26):1303–8.PubMedGoogle Scholar
  64. 64.
    Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall CG. Prospective study of microbial colonization of the nose and skin and infection of the vascular access site in hemodialysis patients. J Clin Microbiol 1988;26(7):1257–62.PubMedGoogle Scholar
  65. 65.
    Weinke T, Schiller R, Fehrenbach FJ, Pohle HD. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1992;11(11):985–9.PubMedGoogle Scholar
  66. 66.
    Pujol M, Pena C, Pallares R, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996;100(5):509–16.PubMedGoogle Scholar
  67. 67.
    Klimek JJ, Marsik FJ, Bartlett RC, Weir B, Shea P, Quintiliani R. Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital. Am J Med 1976;61(3):340–5.PubMedGoogle Scholar
  68. 68.
    Lacey RW. Genetic basis, epidemiology, and future significance of antibiotic resistance in Staphylococcus aureus: a review. J Clin Pathol 1973;26(12):899–913.PubMedGoogle Scholar
  69. 69.
    Rihn JA, Posfay-Barbe K, Harner CD, et al. Community-acquired Methicillin-resistant Staphylococcus Aureus outbreak in a local high school football team unsuccessful interventions. Pediatr Infect Dis J 2005;24(9):841–3.PubMedGoogle Scholar
  70. 70.
    Mallaval FO, Carricajo A, Delavenna F, et al. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital. Clin Microbiol Infect 2004;10(5):459–61.PubMedGoogle Scholar
  71. 71.
    Larssen KW, Jacobsen T, Bergh K, Tvete P, Kvello E, Scheel O. Outbreak of methicillin-resistant Staphylococcus aureus in two nursing homes in Central Norway. J Hosp Infect 2005;60(4):312–6.PubMedGoogle Scholar
  72. 72.
    Lee NE, Taylor MM, Bancroft E, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 2005;40(10):1529–34.PubMedGoogle Scholar
  73. 73.
    Campbell KM, Vaughn AF, Russell KL, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol 2004;42(9):4050–3.PubMedGoogle Scholar
  74. 74.
    Lee SC, Chen KS, Tsai CJ, et al. An outbreak of methicillin-resistant Staphylococcus aureus infections related to central venous catheters for hemodialysis. Infect Control Hosp Epidemiol 2004;25(8):678–84.PubMedGoogle Scholar
  75. 75.
    Berthelot P, Grattard F, Fascia P, et al. Implication of a healthcare worker with chronic skin disease in the transmission of an epidemic strain of methicillin-resistant Staphylococcus aureus in a pediatric intensive care unit. Infect Control Hosp Epidemiol 2003;24(4):299–300.PubMedGoogle Scholar
  76. 76.
    Blok HE, Troelstra A, Kamp-Hopmans TE, et al. Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital. Infect Control Hosp Epidemiol 2003;24(9):679–85.PubMedGoogle Scholar
  77. 77.
    Finland M. Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents. Ann Intern Med 1972;76(6):1009–36.PubMedGoogle Scholar
  78. 78.
    Bou R, Peris M, Perpinan J, Ramos P, Aguilar A. A protracted outbreak of Staphylococcus epidermidis infections among patients undergoing valve replacement. Infect Control Hosp Epidemiol 2004;25(6):498–503.PubMedGoogle Scholar
  79. 79.
    Lark RL, VanderHyde K, Deeb GM, Dietrich S, Massey JP, Chenoweth C. An outbreak of coagulase-negative staphylococcal surgical-site infections following aortic valve replacement. Infect Control Hosp Epidemiol 2001;22(10):618–23.PubMedGoogle Scholar
  80. 80.
    Worthington T, Lambert PA, Elliott TS. Is hospital-acquired intravascular catheter-related sepsis associated with outbreak strains of coagulase-negative staphylococci? J Hosp Infect 2000;46(2): 130–4.PubMedGoogle Scholar
  81. 81.
    Kayser FH. Methicillin-resistant staphylococci 1965–75. Lancet 1975;2(7936):650–3.PubMedGoogle Scholar
  82. 82.
    Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994;13(1):50–5.PubMedGoogle Scholar
  83. 83.
    Boyce JM, Potter-Bynoe G, Opal SM, Dziobek L, Medeiros AA. A common-source outbreak of Staphylococcus epidermidis infections among patients undergoing cardiac surgery. J Infect Dis 1990;161(3):493–9.PubMedGoogle Scholar
  84. 84.
    Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975–1991. Infect Control Hosp Epidemiol 1992;13(10):582–6.PubMedGoogle Scholar
  85. 85.
    Brumfitt W, Hamilton-Miller JM. The worldwide problem of methicillin-resistant Staphylococcus aureus. Drugs Exp Clin Res 1990;16(5):205–14.PubMedGoogle Scholar
  86. 86.
    Smith JM, Marples MJ. A natural reservoir of penicillin-resistant strains of Staphylococcus Aureus. Nature 1964;201:844.PubMedGoogle Scholar
  87. 87.
    Parker MT, Lapage SP. Penicillinase production by Staphylococcus aureus strains from outbreaks of food poisoning. J Clin Pathol 1957;10(4):313–7.PubMedGoogle Scholar
  88. 88.
    Plorde JJ, Sherris JC. Staphylococcal resistance to antibiotics: origin, measurement, and epidemiology. Ann N Y Acad Sci 1974;236(0):413–34.PubMedGoogle Scholar
  89. 89.
    Armstrong-Esther CA. Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann Hum Biol 1976;3(3):221–7.PubMedGoogle Scholar
  90. 90.
    Healy CM, Palazzi DL, Edwards MS, Campbell JR, Baker CJ. Features of invasive staphylococcal disease in neonates. Pediatrics 2004;114(4):953–61.PubMedGoogle Scholar
  91. 91.
    Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 2003;187(9):1452–9.PubMedGoogle Scholar
  92. 92.
    Herwaldt LA, Cullen JJ, French P, et al. Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 2004;25(6):481–4.PubMedGoogle Scholar
  93. 93.
    Harrison LM, Morris JA, Telford DR, Brown SM, Jones K. The nasopharyngeal bacterial flora in infancy: effects of age, gender, season, viral upper respiratory tract infection and sleeping position. FEMS Immunol Med Microbiol 1999;25(1–2):19–28.PubMedGoogle Scholar
  94. 94.
    Khurram IM, Khan SA, Khwaja AA, et al. Risk factors for clinical infection in patients colonized with methicillin resistant Staphylococcus aureus (MRSA). J Pak Med Assoc 2004;54(8):408–12.PubMedGoogle Scholar
  95. 95.
    Gastmeier P, Sohr D, Geffers C, Behnke M, Daschner F, Ruden H. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS). Infection 2005;33(2):50–5.PubMedGoogle Scholar
  96. 96.
    Schneider CR, Buell JF, Gearhart M, et al. Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study. Transplant Proc 2005;37(2):1243–4.PubMedGoogle Scholar
  97. 97.
    Cesur S, Cokca F. Nasal carriage of methicillin-resistant Staphylococcus aureus among hospital staff and outpatients. Infect Control Hosp Epidemiol 2004;25(2):169–71.PubMedGoogle Scholar
  98. 98.
    Eveillard M, Martin Y, Hidri N, Boussougant Y, Joly-Guillou ML. Carriage of methicillin-resistant Staphylococcus aureus among hospital employees: prevalence, duration, and transmission to households. Infect Control Hosp Epidemiol 2004;25(2):114–20.PubMedGoogle Scholar
  99. 99.
    Muder RR, Brennen C, Goetz AM. Infection with methicillin-resistant Staphylococcus aureus among hospital employees. Infect Control Hosp Epidemiol 1993;14(10):576–8.PubMedGoogle Scholar
  100. 100.
    Badiaga S, Menard A, Tissot Dupont H, et al. Prevalence of skin infections in sheltered homeless of Marseilles (France). Eur J Dermatol 2005;15(5):382–6.PubMedGoogle Scholar
  101. 101.
    Bert F, Bellier C, Lassel L, et al. Risk factors for Staphylococcus aureus infection in liver transplant recipients. Liver Transpl 2005;11(9):1093–9.PubMedGoogle Scholar
  102. 102.
    Fang S, Skeete D, Cullen JJ. Preoperative risk factors for postoperative Staphylococcus aureus nosocomial infections. Surg Technol Int 2004;13:35–8.Google Scholar
  103. 103.
    Thompson DS. Methicillin-resistant Staphylococcus aureus in a general intensive care unit. J R Soc Med 2004;97(11):521–6.PubMedGoogle Scholar
  104. 104.
    Toxic-shock syndrome, United States, 1970–1982. MMWR Morb Mortal Wkly Rep 1982;31(16):201–4.Google Scholar
  105. 105.
    Sethi S. Bacterial pneumonia. Managing a deadly complication of influenza in older adults with comorbid disease. Geriatrics 2002;57(3):56–61.PubMedGoogle Scholar
  106. 106.
    Love JB, Wright CA, Hooke DH, Parkin WG, Bills P, Baird R. Exfoliative dermatitis as a risk factor for epidemic spread of methicillin resistant Staphylococcus aureus. Intensive Care Med 1992;18(3):189.PubMedGoogle Scholar
  107. 107.
    Popa ER, Stegeman CA, Kallenberg CG, Tervaert JW. Staphylococcus aureus and Wegener’s granulomatosis. Arthritis Res 2002;4(2):77–9.PubMedGoogle Scholar
  108. 108.
    Saxena AK, Panhotra BR, Venkateshappa CK, et al. The impact of nasal carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus (MRSA & MSSA) on vascular access-related septicemia among patients with type-II diabetes on dialysis. Ren Fail 2002;24(6):763–77.PubMedGoogle Scholar
  109. 109.
    Bassetti S, Battegay M. Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies. Infection 2004;32(3):163–9.PubMedGoogle Scholar
  110. 110.
    Sadoyama G, Gontijo Filho PP. Comparison between the jugular and subclavian vein as insertion site for central venous catheters: microbiological aspects and risk factors for colonization and infection. Braz J Infect Dis 2003;7(2):142–8.PubMedGoogle Scholar
  111. 111.
    Saxena AK, Panhotra BR. Haemodialysis catheter-related bloodstream infections: current treatment options and strategies for prevention. Swiss Med Wkly 2005;135(9–10):127–38.PubMedGoogle Scholar
  112. 112.
    Strachan CJ. The prevention of orthopaedic implant and vascular graft infections. J Hosp Infect 1995;30 Suppl:54–63.PubMedGoogle Scholar
  113. 113.
    Senechal M, LePrince P, Tezenas du Montcel S, et al. Bacterial mediastinitis after heart transplantation: clinical presentation, risk factors and treatment. J Heart Lung Transplant 2004;23(2):165–70.PubMedGoogle Scholar
  114. 114.
    Romano R, Lu D, Holtom P. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among a collegiate football team. J Athl Train 2006;41:141–5.Google Scholar
  115. 115.
    Main CL, Jayaratne P, Haley A, Rutherford C, Smaill F, Fisman DN. Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Can J Infect Dis Med Microbiol 2005;16:343–8.Google Scholar
  116. 116.
    Velázquez-Guadarrama N, Martinez-Aguilar G, Galindo JA, Zuñiga G, Arbo-Sosa A. Methicillin-resistant S. aureus colonization in Mexican children attending day care centres. Clin Invest Med 2009;32:E57–63.Google Scholar
  117. 117.
    Mest DR, Wong DH, Shimoda KJ, Mulligan ME, Wilson SE. Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection. Anesth Analg 1994;78(4):644–50.PubMedGoogle Scholar
  118. 118.
    Bures S, Fishbain JT, Uyehara CF, Parker JM, Berg BW. Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit. Am J Infect Control 2000;28(6): 465–71.PubMedGoogle Scholar
  119. 119.
    Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 2004;39(8):1182–9.PubMedGoogle Scholar
  120. 120.
    Bassetti S, Sherertz RJ, Pfaller MA. Airborne dispersal of Staphylococcus aureus associated with symptomatic rhinitis allergica. Ann Intern Med 2003;139(3):W–W60.PubMedGoogle Scholar
  121. 121.
    Wilson RD, Huang SJ, McLean AS. The correlation between airborne methicillin-resistant Staphylococcus aureus with the presence of MRSA colonized patients in a general intensive care unit. Anaesth Intensive Care 2004;32(2):202–9.PubMedGoogle Scholar
  122. 122.
    Hughes AJ, Ariffin N, Huat TL, et al. Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol 2005;26(1):100–4.PubMedGoogle Scholar
  123. 123.
    Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005;45(3):311–20.PubMedGoogle Scholar
  124. 124.
    Kloos WE, Smith PB. Staphylococci. In: Lennett EH, Hausler WJ, Truant JP, eds. Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology; 1980:83–7.Google Scholar
  125. 125.
    Elek SD, Conen PE. The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. Br J Exp Pathol 1957;38(6):573–86.PubMedGoogle Scholar
  126. 126.
    El-Ahdab F, Benjamin DK, Jr., Wang A, et al. Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. Am J Med 2005;118(3):225–9.PubMedGoogle Scholar
  127. 127.
    Jarrett WA, Ribes J, Manaligod JM. Biofilm formation on tracheostomy tubes. Ear Nose Throat J 2002;81(9):659–61.PubMedGoogle Scholar
  128. 128.
    Adair CG, Gorman SP, Feron BM, et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 1999;25(10):1072–6.PubMedGoogle Scholar
  129. 129.
    Cheung AL, Fischetti VA. The role of fibrinogen in staphylococcal adherence to catheters in vitro. J Infect Dis 1990;161(6):1177–86.PubMedGoogle Scholar
  130. 130.
    Sakata H, Maruyama S. [Study on bacteremia due to community-acquired infection in infants and children without underlying diseases]. Kansenshogaku Zasshi 1998;72(11):1197–201.PubMedGoogle Scholar
  131. 131.
    Fowler VG, Jr., Justice A, Moore C, et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 2005;40(5):695–703.PubMedGoogle Scholar
  132. 132.
    Hsu RB. Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005;26(7):654–7.PubMedGoogle Scholar
  133. 133.
    White MC, Thornton K, Young AE. Early diagnosis and treatment of toxic shock syndrome in paediatric burns. Burns 2005;31(2):193–7.PubMedGoogle Scholar
  134. 134.
    Foster TJ. The Staphylococcus aureus “superbug”. J Clin Invest 2004;114(12):1693–6.PubMedGoogle Scholar
  135. 135.
    Foster TJ, Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998;6(12):484–8.PubMedGoogle Scholar
  136. 136.
    Mazmanian SK, Skaar EP, Gaspar AH, et al. Passage of heme-iron across the envelope of Staphylococcus aureus. Science 2003;299(5608):906–9.PubMedGoogle Scholar
  137. 137.
    Bohach GA, Foster TJ. Staphylococcus aureus exotoxins. In: Fischetti VA, Novick RP, Ferretti JJ, Rood JI, eds. Gram positive bacterial pathogens. Washington, DC: American Society for Microbiology; 1999:367–78.Google Scholar
  138. 138.
    Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1981;1(8228):1017–21.PubMedGoogle Scholar
  139. 139.
    Novick RP. Mobile genetic elements and bacterial toxinoses: the superantigen-encoding pathogenicity islands of Staphylococcus aureus. Plasmid 2003;49(2):93–105.PubMedGoogle Scholar
  140. 140.
    Narita S, Kaneko J, Chiba J, et al. Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT. Gene 2001;268(1–2): 195–206.PubMedGoogle Scholar
  141. 141.
    Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 2004;172(2):1169–76.Google Scholar
  142. 142.
    Davenport DS, Massanari RM, Pfaller MA, Bale MJ, Streed SA, Hierholzer WJ, Jr. Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci. J Infect Dis 1986;153(2):332–9.PubMedGoogle Scholar
  143. 143.
    Ekstedt RD. Immunity to the staphylococci. In: Cohen JO, ed. The Staphylococci. New York: Wiley; 1972:385–418.Google Scholar
  144. 144.
    Koenig MG. The phagocytosis of staphylococci. In: Cohen JO, ed. The Staphylococci. New York: Wiley; 1972:365–83.Google Scholar
  145. 145.
    Quie PG. Infections due to neutrophil malfunction. Medicine (Baltimore) 1973;52(5):411–7.Google Scholar
  146. 146.
    Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev 2005;18(3):521–40.PubMedGoogle Scholar
  147. 147.
    Martin RR, Daugharty H, White A. Staphylococcal antibodies and hypersensitivity to teichoic acids in man. In: Hobby GL, ed. Antimicrobial agents and chemotherapy. Washington, DC: American Society for Microbiology; 1966:91–6.Google Scholar
  148. 148.
    Verhoef J, Peterson P, Kim Y, Sabath LD, Quie PG. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains. Immunology 1977;33(2):191–7.PubMedGoogle Scholar
  149. 149.
    Musher DM, McKenzie SO. Infections due to Staphylococcus aureus. Medicine (Baltimore) 1977;56(5):383–409.Google Scholar
  150. 150.
    Schopfer K, Baerlocher K, Price P, Krech U, Quie PG, Douglas SD. Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcus aureus infections. N Engl J Med 1979;300(15):835–8.PubMedGoogle Scholar
  151. 151.
    Schopfer K, Douglas SD, Wilkinson BJ. Immunoglobulin E antibodies against Staphylococcus aureus cell walls in the sera of patients with hyperimmunoglobulinemia E and recurrent staphylococcal infection. Infect Immun 1980;27(2):563–8.PubMedGoogle Scholar
  152. 152.
    Lenhart N, Mudd S. Staphylococcidal capability of rabbit peritoneal macrophages in relation to infection and elicitation: delayed-type hypersensitivity without increased resistance. Infect Immun 1972;5(5):757–62.PubMedGoogle Scholar
  153. 153.
    Taranta A. Lymphocyte mitogens of staphylococcal origin. Ann N Y Acad Sci 1974;236(0):362–75.PubMedGoogle Scholar
  154. 154.
    Goshi K, Cluff LE, Johnson JE, 3rd, Conti CR. Studies on the pathogenesis of staphylococcal infection. II. The effect of non-specific inflammation. J Exp Med 1961;113:249–57.PubMedGoogle Scholar
  155. 155.
    Karakawa WW, Sutton A, Schneerson R, Karpas A, Vann WF. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun 1988;56(5):1090–5.PubMedGoogle Scholar
  156. 156.
    Fattom AI, Sarwar J, Ortiz A, Naso R. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect Immun 1996;64(5):1659–65.PubMedGoogle Scholar
  157. 157.
    Fattom A, Schneerson R, Szu SC, et al. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. Infect Immun 1990;58(7): 2367–74.PubMedGoogle Scholar
  158. 158.
    Fattom A, Shiloach J, Bryla D, et al. Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate. Infect Immun 1992;60(2):584–9.PubMedGoogle Scholar
  159. 159.
    Robbins JB, Schneerson R, Vann WF, Bryla DA, Fattom A. Prevention of systemic infections caused by group B streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccines. Ann N Y Acad Sci 1995;754:68–82.PubMedGoogle Scholar
  160. 160.
    Welch PG, Fattom A, Moore J, Jr., et al. Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis. J Am Soc Nephrol 1996;7(2):247–53.PubMedGoogle Scholar
  161. 161.
    Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;91(3B):72S–5S.PubMedGoogle Scholar
  162. 162.
    Fowler VG, Jr., Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005;293(24):3012–21.PubMedGoogle Scholar
  163. 163.
    Miro JM, Anguera I, Cabell CH, et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the international collaboration on Endocarditis Merged Database. Clin Infect Dis 2005;41(4):507–14.PubMedGoogle Scholar
  164. 164.
    Chirouze C, Cabell CH, Fowler VG, Jr., et al. Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database. Clin Infect Dis 2004;38(9):1323–7.PubMedGoogle Scholar
  165. 165.
    Huebner J, Goldmann DA. Coagulase-negative staphylococci: role as pathogens. Annu Rev Med 1999;50:223–36.PubMedGoogle Scholar
  166. 166.
    Rupp ME. Coagulase-negative staphylococcal infections: an update regarding recognition and management. Curr Clin Top Infect Dis 1997;17:51–87.PubMedGoogle Scholar
  167. 167.
    Karchmer AW, Archer GL, Dismukes WE. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med 1983;98(4):447–55.PubMedGoogle Scholar
  168. 168.
    Chu VH, Cabell CH, Abrutyn E, et al. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2004;39(10):1527–30.PubMedGoogle Scholar
  169. 169.
    Melish ME, Glasgow LA. Staphylococcal scalded skin syndrome: the expanded clinical syndrome. J Pediatr 1971;78(6):958–67.PubMedGoogle Scholar
  170. 170.
    Haslett TM, Isenberg HD, Hilton E, Tucci V, Kay BG, Vellozzi EM. Microbiology of indwelling central intravascular catheters. J Clin Microbiol 1988;26(4):696–701.PubMedGoogle Scholar
  171. 171.
    Lautenschlager S, Herzog C, Zimmerli W. Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different clinical case definitions. Clin Infect Dis 1993;16(4):567–73.PubMedGoogle Scholar
  172. 172.
    Friedman ND, Kaye KS, Stout JE, et al. Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137(10):791–7.PubMedGoogle Scholar
  173. 173.
    Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 1996;23(2):255–9.PubMedGoogle Scholar
  174. 174.
    Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999;29(2):239–44.PubMedGoogle Scholar
  175. 175.
    Edmond MB, Wenzel RP, Pasculle AW. Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control. Ann Intern Med 1996;124(3):329–34.PubMedGoogle Scholar
  176. 176.
    Ponce de Leon S, Wenzel RP. Hospital-acquired bloodstream infections with Staphylococcus epidermidis. Review of 100 cases. Am J Med 1984;77(4):639–44.PubMedGoogle Scholar
  177. 177.
    Wade JC, Schimpff SC, Newman KA, Wiernik PH. Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 1982;97(4):503–8.PubMedGoogle Scholar
  178. 178.
    Moumile K, Merckx J, Glorion C, Pouliquen JC, Berche P, Ferroni A. Bacterial aetiology of acute osteoarticular infections in children. Acta Paediatr 2005;94(4):419–22.PubMedGoogle Scholar
  179. 179.
    Ross JJ, Shamsuddin H. Sternoclavicular septic arthritis: review of 180 cases. Medicine (Baltimore) 2004;83(3):139–48.Google Scholar
  180. 180.
    Brause BD. Infected orthopedic prostheses. In: Bisno AL, Waldvogel FA, eds. Infections associated with indwelling medical devices. Washington, DC: American Society for Microbiology; 1989:111–27.Google Scholar
  181. 181.
    Brook I. The swollen neck. Cervical lymphadenitis, parotitis, thyroiditis, and infected cysts. Infect Dis Clin North Am 1988;2(1):221–36.PubMedGoogle Scholar
  182. 182.
    Cohen MA, Docktor JW. Acute suppurative parotitis with spread to the deep neck spaces. Am J Emerg Med 1999;17(1):46–9.PubMedGoogle Scholar
  183. 183.
    Spiegel R, Miron D, Sakran W, Horovitz Y. Acute neonatal suppurative parotitis: case reports and review. Pediatr Infect Dis J 2004;23(1):76–8.PubMedGoogle Scholar
  184. 184.
    Nusem-Horowitz S, Wolf M, Coret A, Kronenberg J. Acute suppurative parotitis and parotid abscess in children. Int J Pediatr Otorhinolaryngol 1995;32(2):123–7.PubMedGoogle Scholar
  185. 185.
    Kavanagh D, Prescott GJ, Mactier RA. Peritoneal dialysis-associated peritonitis in Scotland (1999–2002). Nephrol Dial Transplant 2004;19(10):2584–91.PubMedGoogle Scholar
  186. 186.
    Nakamoto H, Hashikita Y, Itabashi A, Kobayashi T, Suzuki H. Changes in the organisms of resistant peritonitis in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial 2004;20:52–7.PubMedGoogle Scholar
  187. 187.
    Peterson PK, Matzke G, Keane WF. Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis 1987;9(3):604–12.PubMedGoogle Scholar
  188. 188.
    Hovelius B, Mardh PA. Staphylococcus saprophyticus as a common cause of urinary tract infections. Rev Infect Dis 1984;6(3):328–37.Google Scholar
  189. 189.
    Lewis JF, Brake SR, Anderson DJ, Vredeveld GN. Urinary tract infection due to coagulase-negative staphylococcus. Am J Clin Pathol 1982;77(6):736–9.PubMedGoogle Scholar
  190. 190.
    Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP. Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 1984;60(5):1014–21.PubMedGoogle Scholar
  191. 191.
    Christin L, Sarosi GA. Pyomyositis in North America: case reports and review. Clin Infect Dis 1992;15(4):668–77.PubMedGoogle Scholar
  192. 192.
    Scharschmidt TJ, Weiner SD, Myers JP. Bacterial Pyomyositis. Curr Infect Dis Rep 2004;6(5):393–6.PubMedGoogle Scholar
  193. 193.
    Schlesinger LS, Ross SC, Schaberg DR. Staphylococcus aureus meningitis: a broad-based epidemiologic study. Medicine (Baltimore) 1987;66(2):148–56.Google Scholar
  194. 194.
    Jensen AG, Espersen F, Skinhoj P, Rosdahl VT, Frimodt-Moller N. Staphylococcus aureus meningitis. A review of 104 nationwide, consecutive cases. Arch Intern Med 1993;153(16):1902–8.PubMedGoogle Scholar
  195. 195.
    Pfaller MA, Wakefield DS, Hollis R, Fredrickson M, Evans E, Massanari RM. The clinical microbiology laboratory as an aid in infection control. The application of molecular techniques in epidemiologic studies of methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 1991;14(3):209–17.PubMedGoogle Scholar
  196. 196.
    Branchini ML, Morthland VH, Tresoldi AT, Von Nowakonsky A, Dias MB, Pfaller MA. Application of genomic DNA subtyping by pulsed field gel electrophoresis and restriction enzyme analysis of plasmid DNA to characterize methicillin-resistant Staphylococcus aureus from two nosocomial outbreaks. Diagn Microbiol Infect Dis 1993;17(4):275–81.PubMedGoogle Scholar
  197. 197.
    van Belkum A, Bax R, Peerbooms P, Goessens WH, van Leeuwen N, Quint WG. Comparison of phage typing and DNA fingerprinting by polymerase chain reaction for discrimination of methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 1993;31(4):798–803.PubMedGoogle Scholar
  198. 198.
    Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986;315(2):91–6.PubMedGoogle Scholar
  199. 199.
    Bissett L. Controlling the risk of MRSA infection: screening and isolating patients. Br J Nurs 2005;14(7):386–90.PubMedGoogle Scholar
  200. 200.
    Ehrenkranz NJ, Meakins JL. Surgical infections. In: Bennett JV, Brachman PS, eds. Hospital Infections. Boston: Little and Brown; 1992:685–710.Google Scholar
  201. 201.
    Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94(3):313–28.PubMedGoogle Scholar
  202. 202.
    Shinefield H, Black S, Fattom A, et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002;346(7):491–6.PubMedGoogle Scholar
  203. 203.
    Archer GL, Armstrong BC. Alteration of staphylococcal flora in cardiac surgery patients receiving antibiotic prophylaxis. J Infect Dis 1983;147(4):642–9.PubMedGoogle Scholar
  204. 204.
    Jaeger K, Zenz S, Juttner B, et al. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. Ann Hematol 2005;84(4):258–62.PubMedGoogle Scholar
  205. 205.
    Taggart T, Kerry RM, Norman P, Stockley I. The use of vancomycin-impregnated cement beads in the management of infection of prosthetic joints. J Bone Joint Surg Br 2002;84(1):70–2.PubMedGoogle Scholar
  206. 206.
    Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348:1342–7.Google Scholar
  207. 207.
    Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135–6.Google Scholar
  208. 208.
    Hanaki H, Labischinski H, Inaba Y, Kondo N, Murakami H, Hiramatsu K. Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. J Antimicrob Chemother 1998;42:315–20.Google Scholar
  209. 209.
    Sieradzki K, Roberts RB, Haber SW, Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1999;340:517–23.Google Scholar
  210. 210.
    Noble MC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992;93:195–8.Google Scholar
  211. 211.
    Sheagren JN. Significance of blood culture isolates of Staphylococcus epidermidis. Arch Intern Med 1987;147(4):635.PubMedGoogle Scholar

Suggested Reading

  1. Doebbeling BN, The epidemiology of methicillin-resistant Staphylococcus aureus colonisation and infection. J Chemother 1995; 7 Suppl 3:99–103.PubMedGoogle Scholar
  2. Cunha BA, Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy. Clin Microbiol Infect 2005;11 Suppl 4:33–42.PubMedGoogle Scholar
  3. Banning M, Transmission and epidemiology of MRSA: current perspectives. Br J Nurs 2005;14:548–554.PubMedGoogle Scholar
  4. Stefani S, Varaldo PE, Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect 2003;9:1179–1186.PubMedGoogle Scholar
  5. Chambers HF, Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997;10:781–791.PubMedGoogle Scholar
  6. Crossley KB, Archer GL (Eds.), The Staphylococci in Human Disease. Churchill-Livingstone, New York, 1997.Google Scholar
  7. Rupp ME, Archer GL, Coagulase negative staphylococci: Pathogens associated with medical progress. Clin Infect Dis 1994;19:231–243.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Division of Infectious DiseasesDuke University Medical CenterDurhamUSA

Personalised recommendations